Yusuke Nakamura to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Yusuke Nakamura has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.145
-
Cancer vaccines. Clin Adv Hematol Oncol. 2011 Oct; 9(10):778-9.
Score: 0.098
-
A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303. Clin Cancer Res. 2012 Jan 15; 18(2):577-84.
Score: 0.025
-
Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors. J Clin Oncol. 2010 Nov 01; 28(31):4674-82.
Score: 0.023